Hi there!
We track 52,000+ AI startups and surface hidden job opportunities that never appear on LinkedIn. Tell us what you're looking for, our AI agent does the searching. It's free and you sign up using Google. Go explore!
Predicta Biosciences
Predicta Biosciences provides blood-based, multiomic diagnostics that enable personalized treatment guidance and high-resolution monitoring for hematologic cancers. The company combines liquid…
Predicta Biosciences
Predicta Biosciences provides blood-based, multiomic diagnostics that enable personalized treatment guidance and high-resolution monitoring for hematologic cancers. The company combines liquid…
TL;DR
Location & focus: Boston-based diagnostics company focused on WGS-based cellular liquid biopsy for multiple myeloma and plasma cell dyscrasias
Flagship product: GenoPredicta — whole-genome sequencing-based clinical assay for blood and bone marrow
Use cases: Noninvasive disease monitoring, treatment decision support for immunotherapies, and discovery of immunotherapy targets
Founding year: 2023
Recent funding: Series A (Oct 2025); reported round about $23.4M; total funding reported ~$28.6M
Company Overview
Problem Domain
Diagnostics and monitoring for hematologic cancers (multiple myeloma and plasma cell dyscrasias); precision oncology and immunotherapy target discovery.
Founded
2023
Industry
Biotechnology Research
Tech Stack
Funding Track Record
23,400,000
Dealroom reports Series A amount $23.4M; Crunchbase lists Engine Ventures as lead
Investor Signal
“Backed by life-sciences and strategic investors including Engine Ventures, Illumina Ventures, Mass General Brigham Ventures, Binney Street Capital and others”
Founders
What we do
Join the Team
Startup jobs. A lot of them.
Your next opportunity is in here somewhere. Sign up to explore 52,000+ startups and their open roles. No spam. No gamification. Just jobs.
52,000+
Startups
60,000+
Open Roles
200+
New This Week
Related Companies
| Company |
|---|
 |
 |
 |
 |
 |